Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' RIBAUD P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 56 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Garderet, L; Bittencourt, H; Kaliski, A; Daniel, MT; Ribaud, P; Socie, G; Gluckman, E
      Treatment of T-prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation

      EUROPEAN JOURNAL OF HAEMATOLOGY
    2. Rocha, V; Carmagnat, MV; Chevret, S; Flinois, O; Bittencourt, H; Esperou, H; Garnier, F; Ribaud, P; Devergie, A; Socie, G; Dal'Cortivo, L; Marolleau, JP; Charron, D; Gluckman, E; Rabian, C
      Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants

      EXPERIMENTAL HEMATOLOGY
    3. Morariu-Zamfir, R; Rocha, V; Devergie, A; Socie, G; Ribaud, P; Esperou, H; Parquet, N; Guardiola, P; Dal Cortivo, L; Bittencourt, H; Garnier, F; Traineau, R; Marolleau, JP; Chevret, S; Gluckman, E
      Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia

      BONE MARROW TRANSPLANTATION
    4. Alberti, C; Bouakline, A; Ribaud, P; Lacroix, C; Rousselot, P; Leblanc, T; Derouin, F
      Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients

      JOURNAL OF HOSPITAL INFECTION
    5. Sulahian, A; Boutboul, F; Ribaud, P; Leblanc, T; Lacroix, C; Derouin, F
      Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study

      CANCER
    6. Socie, G; Mary, JY; Esperou, H; Robert, DV; Aractingi, S; Ribaud, P; Devergie, A; Toubert, ME; Boudou, P; Cathelinau, B; Gluckman, E; Vexiau, P
      Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation

      BRITISH JOURNAL OF HAEMATOLOGY
    7. Chen, Y; Rocha, V; Bittencourt, H; Scieux, C; Loiseau, P; Esperou, H; Devergie, A; Guardiola, P; Socle, G; Chevret, S; Charron, D; Gluckman, E; Ribaud, P
      Relationship between HLA alleles and cytomegalovirus infection after allogeneic hematopoietic stem cell transplant

      BLOOD
    8. Ljungman, P; Deliliers, GL; Platzbecker, U; Matthes-Martin, S; Bacigalupo, A; Einsele, H; Ullmann, J; Musso, M; Trenschel, R; Ribaud, P; Bornhauser, M; Cesaro, S; Crooks, B; Dekker, A; Gratecos, N; Klingebiel, T; Tagliaferri, E; Ullmann, AJ; Wacker, P; Cordonnier, C
      Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients

      BLOOD
    9. Chen, Y; Scieux, C; Garrait, V; Socie, G; Rocha, V; Molina, JM; Thouvenot, D; Morfin, F; Hocqueloux, L; Garderet, L; Esperou, H; Selimi, F; Devergie, A; Leleu, G; Aymard, M; Morinet, F; Gluckman, E; Ribaud, P
      Resistant herpes simplex virus type 1 infection: An emerging concern afterallogeneic stem cell transplantation

      CLINICAL INFECTIOUS DISEASES
    10. Yakoub-Agha, I; de la Salmoniere, P; Ribaud, P; Sutton, L; Wattel, E; Kuentz, M; Jouet, JP; Marit, G; Milpied, N; Deconinck, E; Gratecos, N; Leporrier, M; Chabbert, I; Caillot, D; Damaj, G; Dauriac, C; Dreyfus, F; Francois, S; Molina, L; Tanguy, ML; Chevret, S; Gluckman, E
      Allogeneic bone marrow transplantation for therapy-related myelodysplasticsyndrome and acute myeloid leukemia: A long-term study of 70 patients - Report of the French Society of Bone Marrow Transplantation

      JOURNAL OF CLINICAL ONCOLOGY
    11. Yakoub-Agha, I; Damaj, G; Garderet, L; Bonnet, J; Devergie, A; Esperou, H; Ribaud, P; Socie, G; Gluckman, E
      Severe oesophagitis after allogeneic bone marrow transplantation for Fanconi's anemia

      BONE MARROW TRANSPLANTATION
    12. Parquet, N; Reigneau, O; Humbert, H; Guignard, M; Ribaud, P; Socie, G; Devergie, A; Esperou, H; Gluckman, E
      New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients

      BONE MARROW TRANSPLANTATION
    13. Bellucci, S; Damaj, G; Boval, B; Rocha, V; Devergie, A; Agha, IY; Garderet, L; Ribaud, P; Traineau, R; Socie, G; Gluckman, E
      Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization

      BONE MARROW TRANSPLANTATION
    14. Garderet, L; Bittencourt, H; Sebe, P; Kaliski, A; Claisse, JP; Esperou, H; Ribaud, P; Estrade, V; Gluckman, E; Gattegno, B
      Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients

      TRANSPLANTATION
    15. Ribaud, P; Scieux, C; Freymuth, F; Morinet, F; Gluckman, E
      Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient

      CLINICAL INFECTIOUS DISEASES
    16. Ribaud, P; Chastang, C; Latge, JP; Baffroy-Lafitte, L; Parquet, N; Devergie, A; Esperou, H; Selimi, F; Rocha, V; Derouin, F; Socie, G; Gluckman, E
      Survival and prognostic factors of invasive aspergillosis after allogeneicbone marrow transplantation

      CLINICAL INFECTIOUS DISEASES
    17. Farge, D; Breban, M; Guillevin, L; Piette, JC; Cabane, J; Cherin, P; Cosserat, J; Sicard, D; Ribaud, P; Marolleau, JP; Bouscary, D; Mariette, X; Gisselbrecht, C; Gluckman, E
      Bone marrow graft for the treatment of autoimmune diseases

      PRESSE MEDICALE
    18. Bemba, M; Guardiola, P; Garderet, L; Devergie, A; Ribaud, P; Esperou, H; Noguera, MH; Gluckman, E; Socie, G
      Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria

      BRITISH JOURNAL OF HAEMATOLOGY
    19. SOCIE G; CAYUELA JM; RAYNAL B; ESPEROU H; FUND X; RAFFOUX C; DEVERGIE A; RIBAUD P; MAROLLEAU JP; PARQUET N; SIGAUX F; BRISON O; GLUCKMAN E
      INFLUENCE OF CD34 CELL SELECTION ON THE INCIDENCE OF MIXED CHIMERISM AND MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC UNRELATED DONOR TRANSPLANTATION

      Leukemia
    20. SOCIE G; DEVERGIE A; GIRINSKI T; PIEL G; RIBAUD P; ESPEROU H; PARQUET N; BRISON O; GLUCKMAN E
      TRANSPLANTATION FOR FANCONIS-ANEMIA (FA) - LONG-TERM FOLLOW-UP OF 50 PATIENTS (PTS) TRANSPLANTED FROM A SIBLING DONOR AFTER LOW-DOSE CYCLOPHOSPHAMIDE AND THORACOABDOMINAL IRRADIATION FOR CONDITIONING

      Bone marrow transplantation
    21. DEVERGIE A; PARQUET N; GARDERET L; ESPEROU H; SOCIE G; RIBAUD P; GLUCKMAN E
      ADVANTAGES OF GENO IDENTICAL BMT WITH A NON TOXIC CONDITIONING REGIMEN AS FIRST LINE TREATMENT FOR CHRONIC MYELOID-LEUKEMIA

      Bone marrow transplantation
    22. CHEN Y; LELEU G; RIBAUD P; AZOULAY E; SOCIE G; GLUCKMAN E; SCHLEMMER B
      PREDICTIVE FACTORS OF DEATH IN BMT PATIENTS ADMITTED TO INTENSIVE-CARE UNIT

      Bone marrow transplantation
    23. TRAINEAU R; SCIEUX C; AGBALIKA F; RIBAUD P; SOCIE G; ESPEROU H; DEVERGIE A; PARQUET N; BENBUNAN M; GLUCKMAN E
      USE OF FILTERED BLOOD PRODUCTS FOR THE PREVENTION OF TRANSFUSION-ASSOCIATED CYTOMEGALOVIRUS (CMV) INFECTION AFTER ALLOGENEIC MARROW TRANSPLANT

      Bone marrow transplantation
    24. CHAZALET V; DEBEAUPUIS JP; SARFATI J; LORTHOLARY J; RIBAUD P; SHAH P; CORNET M; THIEN HV; GLUCKMAN E; BRUCKER G; LATGE JP
      MOLECULAR TYPING OF ENVIRONMENTAL AND PATIENT ISOLATES OF ASPERGILLUS-FUMIGATUS FROM VARIOUS HOSPITAL SETTINGS

      Journal of clinical microbiology
    25. MEIGNIN V; DEVERGIE A; BRICE P; BRISON O; PARQUET N; RIBAUD P; COJEAN I; GAULARD P; GLUCKMAN E; SOCIE G; JANIN A
      HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA

      Transplantation
    26. ROCHA V; DEVERGIE A; SOCIE G; RIBAUD P; ESPEROU H; PARQUET N; GLUCKMAN E
      UNUSUAL COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION FOR DYSKERATOSIS-CONGENITA

      British Journal of Haematology
    27. SOCIE G; DEVERGIE A; GIRINSKI T; PIEL G; RIBAUD P; ESPEROU H; PARQUET N; MAAREK O; NOGUERA MH; RICHARD P; BRISON O; GLUCKMAN E
      TRANSPLANTATION FOR FANCONI ANEMIA - LONG-TERM FOLLOW-UP OF 50 PATIENTS TRANSPLANTED FROM A SIBLING DONOR AFTER LOW-DOSE CYCLOPHOSPHAMIDE AND THORACOABDOMINAL IRRADIATION FOR CONDITIONING

      British Journal of Haematology
    28. MEIGNIN V; DEVERGIE A; BRICE P; BRISON O; PARQUET N; RIBAUD P; COJEAN I; GAULARD P; GLUCKMAN E; SOCIE G; JANIN A
      HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA

      British Journal of Haematology
    29. YAKOUBAGHA I; RIBAUD P; DEVERGIE A; GARNIER F; DAMAJ G; ROCHA V; GARDERET L; SELIMI F; GUARDIOLA P; SOCIE G; ESPEROU H; GLUCKMAN E
      BONE-MARROW TRANSPLANTATION FOR THERAPY-RELATED MYELODYSPLASIA (T-MDS) AND ACUTE-LEUKEMIA (T-AL) - EXPERIENCE OF SAINT-LOUIS-HOSPITAL (PARIS)

      British Journal of Haematology
    30. SUTTON L; LEBLOND V; RIBAUD P; JOUET JP
      INDICATIONS AND TIMING OF ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MYELODYSPLASTIC SYNDROMES

      Leukemia & lymphoma
    31. RIBAUD P
      FUNGAL-INFECTIONS AND THE CANCER-PATIENT

      European journal of cancer
    32. TOUBERT ME; SOCIE G; GLUCKMAN E; ARACTINGI S; ESPEROU H; DEVERGIE A; RIBAUD P; PARQUET N; SCHLAGETER MH; BERESSI JP; RAIN JD; VEXIAU P
      SHORT-TERM AND LONG-TERM FOLLOW-UP OF THYROID-DYSFUNCTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITHOUT THE USE OF PREPARATIVE TOTAL-BODY IRRADIATION

      British Journal of Haematology
    33. RIBAUD P; SCIEUX C; PARQUET N; CARBONNEL E; SOCIE G; EMPEROU H; DEVERGIE A; SELIMI F; GLUCKMAN E
      PRELIMINARY-RESULTS OF CIDOFOVIR (HPMPC) FOR THE TREATMENT OF ADENOVIRUS DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) PATIENTS

      Blood
    34. PARQUET N; DEVERGIE A; SOCIE G; RIBAUD P; ESPEROU H; GLUCKMAN E
      VENOOCCLUSIVE DISEASE AFTER BONE-MARROW T RANSPLANTATION - USE OF HEPARIN FOR PREVENTION OF LIVER VENOOCCLUSIVE DISEASE

      Annales de medecine interne
    35. SORIAROYER C; BOUGNOUX ME; SULAHIAN A; RIBAUD P; TRAORE F; GARIN YJF; GLUCKMAN E; DEROUIN F
      RAPD TYPING OF ASPERGILLUS-FUMIGATUS STRA INS - EPIDEMIOLOGIC APPLICATIONS ON A HOSPITAL SITE

      Journal de mycologie medicale
    36. RIBAUD P; GLUCKMAN E
      CRITICAL-REVIEW OF LIPID AMPHOTERICIN-B FORMULATIONS AS TREATMENT OF INVASIVE ASPERGILLOSIS IN PATIENTS WITH HEMATOLOGICAL DISORDERS OR BONE-MARROW TRANSPLANTATION (BMT)

      Journal de mycologie medicale
    37. SULAHIAN A; TABOURET M; RIBAUD P; SARFATI J; GLUCKMAN E; LATGE JP; DEROUIN F
      COMPARISON OF AN ENZYME-IMMUNOASSAY AND LATEX AGGLUTINATION-TEST FOR DETECTION OF GALACTOMANNAN IN THE DIAGNOSIS OF INVASIVE ASPERGILLOSIS

      European journal of clinical microbiology & infectious diseases
    38. MIAUX Y; RIBAUD P
      DIFFERENT ETIOLOGIES OF REVERSIBLE MRI ABNORMALITIES IN TRANSPLANT RECIPIENTS

      Neuroradiology
    39. MIAUX Y; RIBAUD P; WEILL A; MARTINDUVERNEUIL N; COGNARD C; SAVIN D; CHIRAS J
      MR AND CHEMOTHERAPY

      Neurology
    40. SUTTON L; CHASTANG C; RIBAUD P; JOUET JP; KUENTZ M; ATTAL M; REIFFERS J; TIGAUD JM; RIO B; DAURIAC C; LEGROS M; DREYFUS F; LIOURE B; TROUSSARD X; MILPIED N; WITZ F; ORIOL P; CAHN JY; MICHALLET M; GLUCKMAN E; IFRAH N; PICO JL; VILMER E; LEBLOND V
      FACTORS INFLUENCING OUTCOME IN DE-NOVO MYELODYSPLASTIC SYNDROMES TREATED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION - A LONG-TERM STUDY OF 71 PATIENTS

      Blood
    41. PARQUET N; RIBAUD P; CHASTANG C; LATGE JP; SARFATI J; BAFFROYLAFITTE L; DEVERGIE A; ESPEROUBOURDEAU H; TRAORE F; BOUAKLINE A; DEKERVILER E; GLUCKMAN E
      AN OUTBREAK OF INVASIVE ASPERGILLOSIS AMONG BONE-MARROW TRANSPLANTS -CLINICAL-RESULTS AND EPIDEMIOLOGIC FINDINGS

      Experimental hematology
    42. TRAINEAU R; LOISEAU P; GANGNEUX JP; RAVERA N; BENBUNAN M; SOCIE G; RIBAUD P; GLUCKMAN E
      HEPATITIS-C INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANTED PATIENTSAFTER INFUSIONS OF INTRAVENOUS IMMUNOGLOBULIN

      Experimental hematology
    43. MOUSSALEM M; BOURDEAU HE; DEVERGIE A; BARUCHEL A; RIBAUD P; SOCIE G; PARQUET N; TRAINEAU R; HIRSCH I; SCHAISON G; GLUCKMAN E
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN 2ND REMISSION - FACTORS PREDICTIVE OF SURVIVAL, RELAPSE AND GRAFT-VERSUS-HOST DISEASE

      Bone marrow transplantation
    44. LJUNGMAN P; CORDONNIER C; DEBOCK R; EINSELE H; ENGELHARD D; GRUNDY J; LINK H; LOCASCIULLI A; PRENTICE G; REUSSER P; RIBAUD P
      IMMUNIZATIONS AFTER BONE-MARROW TRANSPLANTATION - RESULTS OF A EUROPEAN SURVEY AND RECOMMENDATIONS FROM THE INFECTIOUS-DISEASES WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION

      Bone marrow transplantation
    45. MIAUX Y; RIBAUD P; WILLIAMS M; GUERMAZI A; GLUCKMAN E; BROCHERIOU C; LAVALJEANTET M
      MR OF CEREBRAL ASPERGILLOSIS IN PATIENTS WHO HAVE HAD BONE-MARROW TRANSPLANTATION

      American journal of neuroradiology
    46. RIBAUD P; CHASTANG CI; LATGE JP; SERFATI J; BAFFROYLAFITTE L; PARQUET N; DEVERGIE A; ESPEROU H; SOCIE G; TRAORE F; BOUAKLINE A; GLUCKMAN E
      INVASIVE ASPERGILLOSIS (IA) AFTER ALLOGENEIC MARROW TRANSPLANTATION -SURVIVAL, PROGNOSTIC FACTORS AND MOLECULAR EPIDEMIOLOGY IN 27 CASES OBSERVED IN A SINGLE-CENTER

      Blood
    47. GLUCKMAN E; TRAINEAU R; BROSSARD U; DALCORTIVO L; DEVERGIE A; RIBAUD P; ESPEROU H; SOCIE G; PARQUET N
      PLACENTAL CORD-BLOOD BANKING AND TRANSPLANT

      Blood
    48. RIBAUD P; ESPEROUBOURDEAU H; DEVERGIE A; GLUCKMAN E
      INVASIVE ASPERGILLOSIS AND ALLOGENEIC BON E-MARROW TRANSPLANTATION

      Pathologie et biologie
    49. LOCASCIULLI A; ALBERTI A; DEBOCK R; CORDONNIER C; EINSELE H; ENGELHARD D; GRUNDY J; REUSSER P; RIBAUD P; LJUNGMAN P
      IMPACT OF LIVER-DISEASE AND HEPATITIS INFECTIONS ON ALLOGENEIC BONE-MARROW TRANSPLANTATION IN EUROPE - A SURVEY FROM THE EUROPEAN BONE-MARROW TRANSPLANTATION (EBMT) GROUP INFECTIOUS-DISEASES WORKING PARTY

      Bone marrow transplantation
    50. FOOT ABM; GARIN YJF; RIBAUD P; DEVERGIE A; DEROUIN F; GLUCKMAN E
      PROPHYLAXIS OF TOXOPLASMOSIS INFECTION WITH PYRIMETHAMINE SULFADOXINE(FANSIDAR) IN BONE-MARROW TRANSPLANT RECIPIENTS/

      Bone marrow transplantation
    51. SOCIE G; HENRYAMAR M; DEVERGIE A; ESPEROUBOURDEAU H; RIBAUD P; TRAINEAU R; GLUCKMAN E
      MALIGNANT DISEASES AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - AN UPDATED OVERVIEW

      Nouvelle revue francaise d'hematologie
    52. DEVERGIE A; TRAINEAU R; ESPEROUBOURDEAU H; RIBAUD P; SOCIE G; RICHARD P; SELIMI F; HIRSCH I; GLUCKMAN E
      PROGRESS IN THE PREVENTION OF CYTOMEGALOVIRUS-INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Nouvelle revue francaise d'hematologie
    53. SOCIE G; SELIMI F; SEDEL L; FRIJA J; DEVERGIE A; BOURDEAU HE; RIBAUD P; GLUCKMAN E
      AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - CLINICAL FINDINGS, INCIDENCE AND RISK-FACTORS

      British Journal of Haematology
    54. LJUNGMAN P; DEBOCK R; CORDONNIER C; EINSELE H; ENGELHARD D; GRUNDY J; LOCASCIULLI A; REUSSER P; RIBAUD P
      PRACTICES FOR CYTOMEGALOVIRUS DIAGNOSIS, PROPHYLAXIS AND TREATMENT INALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS - A REPORT FROM THE WORKING PARTY FOR INFECTIOUS-DISEASES OF THE EBMT

      Bone marrow transplantation
    55. SAUGIERVEBER P; DEVERGIE A; SULAHIAN A; RIBAUD P; TRAORE F; BOURDEAUESPEROU H; GLUCKMAN E; DEROUIN F
      EPIDEMIOLOGY AND DIAGNOSIS OF INVASIVE PULMONARY ASPERGILLOSIS IN BONE-MARROW TRANSPLANT PATIENTS - RESULTS OF A 5-YEAR RETROSPECTIVE STUDY

      Bone marrow transplantation
    56. DEVERGIE A; SOCIE G; ESPEROUBOURDEAU H; RIBAUD P; TRAINEAU R; GLUCKMAN E
      INFLUENCE OF VARIOUS CONDITIONING REGIMENS ON THE OUTCOME OF BONE-MARROW TRANSPLANTATION FOR LEUKEMIA

      Nouvelle revue francaise d'hematologie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/05/20 alle ore 14:35:40